We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.05B
AUM Growth
+$375M
Cap. Flow
+$361M
Cap. Flow %
34.49%
Top 10 Hldgs %
24.89%
Holding
5,677
New
1,360
Increased
1,920
Reduced
1,136
Closed
1,108

Top Buys

Rank Stock Value
1
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$24.1M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$23.4M
3
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$22.7M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$22.6M
5
IBB icon
iShares Biotechnology ETF
IBB
+$15.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$48M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$16.2M
3
EZU icon
iShare MSCI Eurozone ETF
EZU
+$10.9M
4
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$9.69M
5
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$9.09M

Sector Composition

Rank Sector Weight
1 Financials 6.05%
2 Technology 5.64%
3 Industrials 5.17%
4 Consumer Discretionary 4.28%
5 Healthcare 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACWX icon
3476
iShares MSCI ACWI ex US ETF
ACWX
$11.8B
$4K ﹤0.01%
115
-17,426
-99% -$692K
AEG icon
3477
Aegon
AEG
$14.1B
$4K ﹤0.01%
+1,481
New +$5.57K
AIV
3478
Aimco
AIV
$383M
$4K ﹤0.01%
751
-9,608
-93% -$53.2K
AKTX
3479
Akari Therapeutics
AKTX
$12.3M
– –
0
– –
ARCC icon
3480
Ares Capital
ARCC
$14.4B
$4K ﹤0.01%
+304
New +$4.51K
AROC icon
3481
Archrock
AROC
$5.8B
$4K ﹤0.01%
469
+364
+347% +$2.87K
AUPH icon
3482
Aurinia Pharmaceuticals
AUPH
$2.11B
$4K ﹤0.01%
1,000
+700
+233% +$1.91K
AXSM icon
3483
Axsome Therapeutics
AXSM
$10.9B
$4K ﹤0.01%
481
-220
-31% -$2.03K
BBGI icon
3484
Beasley Broadcasting Group
BBGI
$40M
$4K ﹤0.01%
50
-7
-12% -$593
BRF icon
3485
VanEck Brazil Small-Cap ETF
BRF
$21.4M
$4K ﹤0.01%
+287
New +$3.77K
BWEN icon
3486
Broadwind
BWEN
$109M
$4K ﹤0.01%
1,039
+839
+420% +$3.06K
CCD
3487
Calamos Dynamic Convertible & Income Fund
CCD
$742M
$4K ﹤0.01%
200
-150
-43% -$2.67K
CDXS icon
3488
Codexis
CDXS
$158M
$4K ﹤0.01%
996
-12,223
-92% -$44.8K
CENTA icon
3489
Central Garden & Pet Co Class A
CENTA
$2.44B
$4K ﹤0.01%
240
-10
-4% -$143
CEV
3490
Eaton Vance California Municipal Income Trust
CEV
$73.6M
$4K ﹤0.01%
300
+190
+173% +$2.68K
CLMB icon
3491
Climb Global Solutions
CLMB
$519M
$4K ﹤0.01%
984
-424
-30% -$1.84K
CLSD
3492
DELISTED
Clearside Biomedical
CLSD
$4K ﹤0.01%
+33
New +$3.46K
CRESY
3493
Cresud
CRESY
$773M
$4K ﹤0.01%
+353
New +$3.66K
HERZ
3494
Herzfeld Credit Income Fund
HERZ
$31.6M
$4K ﹤0.01%
+77
New +$3.89K
DAX icon
3495
Global X DAX Germany ETF
DAX
$236M
$4K ﹤0.01%
171
-400
-70% -$9.6K
DLHC icon
3496
DLH Holdings
DLHC
$69.9M
$4K ﹤0.01%
+734
New +$3.15K
DMLP icon
3497
Dorchester Minerals
DMLP
$1.26B
$4K ﹤0.01%
302
-483
-62% -$6.44K
DOC icon
3498
Healthpeak Properties
DOC
$14.8B
$4K ﹤0.01%
139
-1,591
-92% -$49.4K
ECC
3499
Eagle Point Credit Company
ECC
$513M
$4K ﹤0.01%
+265
New +$4.54K
ELSE
3500
DELISTED
Electro-Sensors
ELSE
$4K ﹤0.01%
1,275
+685
+116% +$2.29K
138 139
140
141 142

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2016 Portfolio in Review

As of Q2 2016, Tower Research Capital (TRC) held 5,677 positions worth $1.05B, up 56% from $672M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $361M of net new capital in Q2 2016, opening 1,360 new positions and adding to 1,920 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.

By sector, the portfolio is most concentrated in Financials at 6.1% of assets, up from 2.5% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $48M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2016 buy was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.
  • Tower Research Capital (TRC) added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q2 2016, an estimated $24.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2016 reduction was iShares Russell 2000 ETF, cutting an estimated $48M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2016, selling an estimated $9.09M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.05B portfolio in Q2 2016.
  • Tower Research Capital (TRC) opened 1,360 new positions and closed 1,108 in Q2 2016.
  • Tower Research Capital (TRC)'s portfolio value rose 56% quarter-over-quarter to $1.05B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.